Merck Canada will invest $6.8 million in AmorChem, a Quebec life sciences venture capital fund. The contribution follows a commitment made by Merck in 2010 to invest $100 million over five years in biopharmaceutical research and development in Quebec.
Toronto will be the home of GE Healthcare’s first global Pathology Imaging Centre of Excellence, a cutting-edge, one-of-a-kind R&D facility that will advance both the technology and adoption of digital pathology solutions,
Each year is marked by a few major events and the people associated. The close of a calendar year allows us at Business Review Canada to highlight the stories that had the biggest impacts. Starting today, we will count down the top 7 stories that shaped business in 2010.
There is an old saying, “don’t let a good crisis go to waste.”
The people at Medworxx Inc., a provider of healthcare solutions for patient flow, compliance and education, apparently know it.
Apparently, the questionable incurred costs for private hospital consultants in Ontario, detailed in a report by the Auditor General recently, aren’t weighing down the whole system.
Ontario’s health system is sick, according to a special report from Auditor General Jim McCarter detailing the controversial role of consultants in healthcare.
Cancer diagnostics company Biomoda, Inc. has received a notice of allowance for a Canadian patent application for a method of using its proprietary porphyrin-based compound that binds to cancer cells and causes them to fluoresce under specific frequencies of light when viewed under a fl
Health Canada approved 11 of Axxess Pharma Inc.’s new prescription and non-prescription drugs as management anticipates annual sales from the recently approved drugs to exceed $6 million.
Toronto-based Celestica Inc., a global leader in the delivery of end-to-end product lifecycle solutions, augments its growing healthcare division with the acquisition Austria’s Allied Panels Entwicklungs-und Produktions GmbH.
Toronto’s Sentinelle Medical, a leader in breast imaging technologies using high-field strength MRI to help in the earlier detection and better treatment of breast cancer, was acquired by US-based Hologic Inc.
Chemaphor Inc. announced that it has launched a stem cell regenerative therapy for pets and horses in Canada.
Chemaphor has gained access to the exclusive marketing rights for this procedure in Canada through the acquisition of a private company, of which the ultimate licensor of this regenerative stem cell therapy is Vet-Stem Inc. of California.
The Honourable Tony Clement, Minister of Industry, and the Honourable Gary Goodyear, Minister of State, welcomed renowned scientist Dr. Stephen Hawking to Canada.
BIOTECanada confirmed a national team of industry leaders whose expertise will proliferate Canada’s $84 billion bio-economy at its 2010 annual general meeting in Montreal.
Canada’s banks must contend with regulatory reform measures aboard because staying competitive globally requires expanding operations into foreign markets, according to Capco, a leading global provider of consulting and managed services to the financial services industry. The issue is...
Canadian executive search firm Four Corners Group goes global via a new partnership with InterSearch Worldwide, a robust international network of search firms.
Four Corners Group opens a new pipeline in its search resources by tapping into InterSearch’s global level and access to international candidates.
A division of Elliott & Page Limited, one of Canada's leading integrated financial services providers, Manulife Mutual Funds has rebranded and relaunched the Value Leaders Portfolios as the Manulife Leaders Portfolios.